ARCHIVES

December Business & Regulatory Report included in this issue.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007